|
1
|
Santos NC, Figueira-Coelho J,
Martins-Silva J and Saldanha C: Multidisciplinary utilization of
dimethyl sulfoxide: Pharmacological, cellular and molecular
aspects. Biochem Pharmacol. 65:1035–1041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pectasides D, Pectasides E, Constantinidou
A and Aravantinos G: Current management of stage I testicular
non-seminomatous germ cell tumours. Crit Rev Oncol Hematol.
70:114–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Skakkebaek N: Possible carcinoma-in-situ
of the testis. Lancet. 2:516–517. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ulbright TM: Germ cell neoplasms of the
testis. Am J Surg Pathol. 17:1075–1091. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Masters JR and Köberle B: Curing
metastatic cancer: Lessons from testicular germ-cell tumours. Nat
Rev Cancer. 3:517–525. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sonneveld DJ, Hoekstra HJ, van der Graaf
WT, et al: Improved long term survival of patients with metastatic
nonseminomatous testicular germ cell carcinoma in relation to
prognostic classification systems during the cisplatin era. Cancer.
91:1304–1315. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Freedman LS, Parkinson MC, Jones WG, et
al: Histopathology in the prediction of relapse of patients with
stage I testicular teratoma treated by orchidectomy alone. Lancet.
2:294–298. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Read G, Stenning SP, Cullen MH, et al:
Medical Research Council prospective study of surveillance for
stage I testicular teratoma. Medical Research Council Testicular
Tumors Working Party. J Clin Oncol. 10:1762–1768. 1992.PubMed/NCBI
|
|
9
|
Oliver RT, Ong J, Shamash J, et al:
Long-term follow-up of Anglian Germ Cell Cancer Group surveillance
versus patients with stage 1 nonseminoma treated with adjuvant
chemotherapy. Urology. 63:556–561. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cullen MH, Stenning SP, Parkinson MC, et
al: Short-course adjuvant chemotherapy in high-risk stage I
nonseminomatous germ cell tumors of the testis: A Medical Research
Council report. J Clin Oncol. 14:1106–1113. 1996.PubMed/NCBI
|
|
11
|
Guney S, Guney N, Sonmez NC and Ergenekon
E: Risk-adapted management for patients with clinical stage I
non-seminomatous germ cell tumour of the testis. Med Oncol.
26:136–142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vergouwe Y, Steyerberg EW, Eijkemans MJ,
et al: Predictors of occult metastasis in clinical stage I
nonseminoma: A systematic review. J Clin Oncol. 21:4092–4099. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amato RJ, Ro JY, Ayala AG and Swanson DA:
Risk-adapted treatment for patients with clinical stage I
nonseminomatous germ cell tumor of the testis. Urology. 63:144–149.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dunn TA, Schmoll HJ, Grünwald V, Bokemeyer
C and Casper J: Comparative cytotoxicity of oxaliplatin and
cisplatin in non-seminomatous germ cell cancer cell lines. Invest
New Drugs. 15:109–114. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Looijenga LH, Gillis AJ, Stoop HJ, Hersmus
R and Oosterhuis JW: Chromosomes and expression in human testicular
germ-cell tumors: Insight into their cell of origin and
pathogenesis. Ann NY Acad Sci. 1120:187–214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chano T, Ikegawa S, Kontani K, Okabe H,
Baldini N and Saeki Y: Identification of RB1CC1, a novel human gene
that can induce RB1 in various human cells. Oncogene. 21:1295–1298.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Minami K, Chano T, Kawakami T, Ushida H,
Kushima R, Okabe H, Okada Y and Okamoto K: DNMT3L is a novel marker
and is essential for the growth of human embryonal carcinoma. Clin
Cancer Res. 16:2751–2759. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clark SJ, Harrison J, Paul CL and Frommer
M: High sensitivity mapping of methylated cytosines. Nucleic Acids
Res. 22:2990–2997. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Frevel MA, Sowerby SJ, Petersen GB and
Reeve AE: Methylation sequencing analysis refines the region of H19
epimutation in Wilms tumor. J Biol Chem. 274:29331–29340. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang AS, Estécio MR, Doshi K, Kondo Y,
Tajara EH and Issa JP: A simple method for estimating global DNA
methylation using bisulfite PCR of repetitive DNA elements. Nucleic
Acids Res. 32:e382004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ushida H, Chano T, Minami K, Kita H,
Kawakami T, Okabe H, Okada Y and Okamoto K: Therapeutic potential
of SOX2 inhibition for embryonal carcinoma. J Urol. 187:1876–1881.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wohrle D, Salat U, Hameister H, Vogel W
and Steinbach P: Demethylation, reactivation and destabilization of
human fragile X full-mutation alleles in mouse embryocarcinoma
cells. Am J Hum Genet. 69:504–515. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wermann H, Stoop H, Gillis AJ, Honecker F,
van Gurp RJ, Ammerpohl O, Richter J, Oosterhuis JW, Bokemeyer C and
Looijenga LH: Global DNA methylation in fetal human germ cells and
germ cell tumours: Association with differentiation and cisplatin
resistance. J Pathol. 221:433–442. 2010.PubMed/NCBI
|
|
24
|
Koul S, McKiernan JM, Narayan G,
Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M,
Reuter VE, Bosl GJ, Chaganti RS and Murty VV: Role of promoter
hypermethylation in cisplatin treatment response of male germ cell
tumors. Mol Cancer. 3:162004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Adler S, Pellizzer C, Paparella M, Hartung
T and Bremer S: The effects of solvents on embryonic stem cell
differentiation. Toxicol In Vitro. 20:265–271. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pal R, Mamidi MK, Das AK and Bhonde R:
Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation
potential of human embryonic stem cells. Arch Toxicol. 86:651–661.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okamoto K: Epigenetics: A way to
understand the origin and biology of testicular germ cell tumors.
Int J Urol. 19:504–511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ushida H, Kawakami T, Minami K, Chano T,
Okabe H, Okada Y and Okamoto K: Methylation profile of DNA
repetitive elements in human testicular germ cell tumor. Mol
Carcinog. 51:711–722. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bourc'his D and Bestor TH: Meiotic
catastrophe and retrotransposon reactivation in male germ cells
lacking Dnmt3L. Nature. 431:96–99. 2004. View Article : Google Scholar : PubMed/NCBI
|
